Cargando…
Lung Cancer and Heart Disease Risks Associated With Low-Dose Pulmonary Radiotherapy to COVID-19 Patients With Different Background Risks
PURPOSE: The respiratory disease COVID-19 reached global pandemic status in 2020. Excessive inflammation is believed to result in the most severe symptoms and death from this disease. Because treatment options for patients with severe COVID-19 related pulmonary symptoms remain limited, whole-lung lo...
Autores principales: | Shuryak, Igor, Kachnic, Lisa A., Brenner, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078051/ https://www.ncbi.nlm.nih.gov/pubmed/33930480 http://dx.doi.org/10.1016/j.ijrobp.2021.04.018 |
Ejemplares similares
-
In Reply to Welsh et al.
por: Shuryak, Igor, et al.
Publicado: (2021) -
Low Doses of Radiation Increase the Immunosuppressive Profile of Lung Macrophages During Viral Infection and Pneumonia
por: Meziani, Lydia, et al.
Publicado: (2021) -
Minimizing second cancer risk following radiotherapy: current perspectives
por: Ng, John, et al.
Publicado: (2014) -
Point‐of‐care echocardiography of the right heart improves acute heart failure risk stratification for low‐risk patients: The REED‐AHF prospective study
por: Harrison, Nicholas E., et al.
Publicado: (2022) -
Genetic background influences expression and function of the cation channel TRPM4 in the mouse heart
por: Medert, Rebekka, et al.
Publicado: (2020)